Works matching AU Furuya, Ken

Results: 113
    1
    2

    Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.

    Published in:
    Hepatology Research, 2021, v. 51, n. 9, p. 979, doi. 10.1111/hepr.13693
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Kubo, Akinori;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Shigesawa, Taku;
    • Nakamura, Akihisa;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Yamamoto, Yoshiya
    Publication type:
    Article
    3

    Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.

    Published in:
    Hepatology Research, 2020, v. 50, n. 8, p. 966, doi. 10.1111/hepr.13511
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Ito, Jun;
    • Yamamoto, Yoshiya;
    • Kobayashi, Tomoe;
    • Meguro, Takashi;
    • Saga, Akiyoshi;
    • Miyagishima, Takuto
    Publication type:
    Article
    4

    Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 11, p. 1294, doi. 10.1111/hepr.13399
    By:
    • Suzuki, Kazuharu;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Baba, Masaru;
    • Kimura, Megumi;
    • Maehara, Osamu;
    • Shimazaki, Tomoe;
    • Yamamoto, Koji;
    • Shigesawa, Taku;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Morikawa, Kenichi;
    • Ogawa, Koji;
    • Sakamoto, Naoya
    Publication type:
    Article
    5

    Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1207, doi. 10.1111/hepr.13391
    By:
    • Izumi, Takaaki;
    • Sho, Takuya;
    • Morikawa, Kenichi;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Umemura, Machiko;
    • Shimazaki, Tomoe;
    • Kimura, Megumi;
    • Nakai, Masato;
    • Suda, Goki;
    • Natsuizaka, Mitsuteru;
    • Ogawa, Koji;
    • Kudo, Yusuke;
    • Nishida, Mutsumi;
    • Ono, Kota;
    • Baba, Masaru;
    • Furuya, Ken
    Publication type:
    Article
    6

    Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction.

    Published in:
    Hepatology Research, 2018, v. 48, n. 7, p. 529, doi. 10.1111/hepr.13056
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Nagasaka, Atsushi;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Kumagai, Kenichi;
    • Uebayashi, Minoru;
    • Terashita, Katsumi;
    • Kobayashi, Tomoe;
    • Tsunematsu, Izumi;
    • Onodera, Manabu;
    • Meguro, Takashi;
    • Kimura, Megumi;
    • Ito, Jun;
    • Umemura, Machiko;
    • Izumi, Takaaki;
    • Kawagishi, Naoki;
    • Ohara, Masatsugu;
    • Ono, Yuji;
    • Nakai, Masato
    Publication type:
    Article
    7

    Add‐on effects of fluvastatin in simeprevir/pegylated‐interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study.

    Published in:
    Hepatology Research, 2018, v. 48, n. 3, p. E146, doi. 10.1111/hepr.12938
    By:
    • Suda, Goki;
    • Ito, Jun;
    • Nagasaka, Atsushi;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Okamoto, Munenori;
    • Terashita, Katsumi;
    • Kobayashi, Tomoe;
    • Tsunematsu, Izumi;
    • Yoshida, Junichi;
    • Meguro, Takashi;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Kimura, Megumi;
    • Umemura, Machiko;
    • Izumi, Takaaki;
    • Tsukuda, Yoko;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru
    Publication type:
    Article
    8

    Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.

    Published in:
    Hepatology Research, 2017, v. 47, n. 11, p. 1127, doi. 10.1111/hepr.12851
    By:
    • Suda, Goki;
    • Nagasaka, Atsushi;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Kumagai, Kenichi;
    • Kudo, Mineo;
    • Terashita, Katsumi;
    • Kobayashi, Tomoe;
    • Tsunematsu, Izumi;
    • Yoshida, Junichi;
    • Meguro, Takashi;
    • Kimura, Megumi;
    • Ito, Jun;
    • Umemura, Machiko;
    • Izumi, Takaaki;
    • Tsunematsu, Seiji;
    • Sato, Fumiyuki;
    • Tsukuda, Yoko;
    • Nakai, Masato;
    • Sho, Takuya
    Publication type:
    Article
    9

    Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.

    Published in:
    Cancers, 2022, v. 14, n. 16, p. 3938, doi. 10.3390/cancers14163938
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Baba, Masaru;
    • Ogawa, Koji;
    • Kubo, Akinori;
    • Tokuchi, Yoshimasa;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Kimura, Megumi;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Nakamura, Akihisa;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    An Elderly Man with Purple Urine.

    Published in:
    Journal of Clinical & Experimental Investigations, 2021, v. 12, n. 4, p. 1, doi. 10.29333/jcei/11266
    By:
    • Hideaki Minami;
    • Masashi Ohe;
    • Furuya, Ken
    Publication type:
    Article
    21
    22

    Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000527759
    By:
    • Hosoda, Shunichi;
    • Suda, Goki;
    • Sho, Takuya;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Yang, Zijian;
    • Yoshida, Sonoe;
    • Kubo, Akinori;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Nakamura, Akihisa;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 23, p. 4294, doi. 10.1002/cncr.32406
    By:
    • Hamauchi, Satoshi;
    • Furuse, Junji;
    • Takano, Toshimi;
    • Munemoto, Yoshinori;
    • Furuya, Ken;
    • Baba, Hideo;
    • Takeuchi, Manabu;
    • Choda, Yasuhiro;
    • Higashiguchi, Takashi;
    • Naito, Tateaki;
    • Muro, Kei;
    • Takayama, Koichi;
    • Oyama, Shusuke;
    • Takiguchi, Toru;
    • Komura, Naoyuki;
    • Tamura, Kazuo
    Publication type:
    Article
    38
    39
    40

    Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting.

    Published in:
    JGH Open, 2020, v. 4, n. 1, p. 54, doi. 10.1002/jgh3.12209
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Shimazaki, Tomoe;
    • Maehara, Osamu;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Yamamoto, Yoshiya;
    • Kobayashi, Tomoe;
    • Meguro, Takashi
    Publication type:
    Article
    41

    Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-56947-1
    By:
    • Ogawa, Koji;
    • Kobayashi, Takashi;
    • Furukawa, Jun-ichi;
    • Hanamatsu, Hisatoshi;
    • Nakamura, Akihisa;
    • Suzuki, Kazuharu;
    • Kawagishi, Naoki;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Nakai, Masato;
    • Sho, Takuya;
    • Suda, Goki;
    • Morikawa, Kenichi;
    • Baba, Masaru;
    • Furuya, Ken;
    • Terashita, Katsumi;
    • Kobayashi, Tomoe;
    • Onodera, Manabu;
    • Horimoto, Takahiro;
    • Shinada, Keisuke
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50